Adrenomedullin vs Elabela — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Adrenomedullin (ADM) is a 52-amino acid vasoactive peptide first isolated from human pheochromocytoma tissue in 1993. It is now recognized as a pleiotropic hormone produced widely throughout the body, with highest expression in the adrenal medulla, heart, lung, kidney, and vascul...
Calculate Adrenomedullin dose →Elabela (also called Apela or Toddler) is the second endogenous peptide ligand for the APJ receptor, discovered in 2013 independently through two approaches: as an essential zebrafish cardiac development factor (Toddler) and as a novel human APJ ligand (Elabela). Unlike apelin pe...
Calculate Elabela dose →| Parameter | Adrenomedullin | Elabela |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Clinical | Research |
| Half-Life | 22 min (plasma) | Short (minutes, estimated) |
| Typical Dose | 2-10 ng/kg/min (IV infusion) | 5-500 nmol/kg (animal) |
| Frequency | Acute infusion or short course | Variable |
| Route | Intravenous, Subcutaneous | Subcutaneous, Intravenous |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.